Phase I Dose-Escalation and Pharmacokinetic Study of Intravenous Aflibercept in Combination with Docetaxel, Cisplatin, and 5-Fluorouracil in Patients with Advanced Solid Malignancies

Publisher： Karger

E-ISSN： 1423-0232|90|1|10-20

ISSN： 0030-2414

Source： Oncology, Vol.90, Iss.1, 2016-0, pp. : 10-20

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A phase I clinical and pharmacokinetic study of tipifarnib in combination with docetaxel in patients with advanced solid malignancies

By Awada Ahmad   Zhang Steven   Gil Thierry   de Valeriola Dominique   Lalami Yassine   De Porre Peter   Piccart-Gebhart Martine J.  

Current Medical Research and Opinion, Vol. 23, Iss. 5, 2007-05 ,pp. : 991-1003

Informa Healthcare

Access to resources Recommend Favorite

Mitomycin C, 5-Fluorouracil, Leucovorin, and Oxaliplatin as a Salvage Therapy for Patients with Cisplatin-Resistant Advanced Gastric Cancer: A Phase I Dose Escalation Trial

By  

Oncology Research and Treatment, Vol. 30, Iss. 1-2, 2007-01 ,pp. : 29-34

Karger

Access to resources Recommend Favorite

Multicenter Phase I/II Study of Docetaxel, Cisplatin and Fluorouracil Combination Chemotherapy in Patients with Advanced or Recurrent Squamous Cell Carcinoma of the Esophagus

By  

Oncology, Vol. 80, Iss. 5-6, 2011-07 ,pp. : 307-313

Karger

Access to resources Recommend Favorite

A Phase I Study of Weekly Docetaxel, 24-Hour Infusion of High-Dose Fluorouracil/Leucovorin and Cisplatin in Patients with Advanced Gastric Cancer

By  

Oncology, Vol. 63, Iss. 3, 2002-10 ,pp. : 239-247

Karger

Access to resources Recommend Favorite

A Phase I Dose Escalation and Pharmacodynamic Study of SU5416 (Semaxanib) Combined with Weekly Cisplatin and Irinotecan in Patients with Advanced Solid Tumors

By  

Oncology Research and Treatment, Vol. 36, Iss. 11, 2013-10 ,pp. : 657-660

Karger

Access to resources Recommend Favorite